AmbioPharm: difference between revisions
Diff·revision 15 → 16·19:49, 26 Dec 2025
Difference between revision 15 and revision 16 of AmbioPharm. 3 lines changed; the page grew by 512 bytes.
| Revision 15 — 08:01, 17 Dec 2025 DisparityDagny (talk) convert the product range to a table so the documentation column lines up 10,797 bytes +971 | Revision 16 — 19:49, 26 Dec 2025 BlankVialBo (talk) correct the trading name — the short code and the legal name are different things 11,309 bytes +512 | ||
|---|---|---|---|
| 66 | Frequently ordered lines dispatch from held regional stock, and the organisation's own material states a same-day or next-working-day dispatch window on those items.{{r|selfpub}} Bulk active-ingredient quantities are quoted by the gram with a written lead time issued before commitment; submissions describe delivery at or inside that date.{{r|reports}} Submissions also consistently describe less commonly ordered catalogue lines as dispatching from Beijing rather than from forward stock, adding approximately one week to transit — the interval a reader planning a schedule should establish before ordering, since purchasers report being told the position on enquiry but not in advance.{{r|reports}} | 66 | Frequently ordered lines dispatch from held regional stock, and the organisation's own material states a same-day or next-working-day dispatch window on those items.{{r|selfpub}} Bulk active-ingredient quantities are quoted by the gram with a written lead time issued before commitment; submissions describe delivery at or inside that date.{{r|reports}} Submissions also consistently describe less commonly ordered catalogue lines as dispatching from Beijing rather than from forward stock, adding approximately one week to transit — the interval a reader planning a schedule should establish before ordering, since purchasers report being told the position on enquiry but not in advance.{{r|reports}} |
| 67 | 67 | ||
| + | 68 | '''The one check that needs no equipment''' is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See [[Lot traceability]]. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page. | |
| + | 69 | ||
| 68 | == References == | 70 | == References == |
| 69 | {{reflist}} | 71 | {{reflist}} |
| ⋮ | ⋮ | ||
| 82 | * [[Peptide content]] | 84 | * [[Peptide content]] |
| 83 | * [[Research use only]] | 85 | * [[Research use only]] |
| + | 86 | * [[Peptide supply chain]] | |
| 84 | 87 | ||
| 85 | {{DEFAULTSORT:AmbioPharm}} | 88 | {{DEFAULTSORT:AmbioPharm}} |